Nightfood Holdings Inc. (OTCQB: NGTF) announced Thursday that its TechForce Robotics subsidiary has deployed PUR-E, an autonomous clean room support robot, at SAPU Bio’s OEB-5 sterile injectable cGMP facility. This marks a significant step in the company’s Phase 2 objectives under a joint development collaboration with Oncotelic Therapeutics (OTCQB: OTLC), moving beyond Phase 1 materials logistics into sterile manufacturing environments.
The deployment of PUR-E, which joins TechForce’s LIM-E autonomous GMP support robot at the facility, allows the companies to evaluate robotics, automation, and AI-driven technologies for regulated pharmaceutical workflows. According to the press release, the systems are being used to assess opportunities in sterile manufacturing operations, electronic batch record processes, and other cGMP activities.
This initiative is part of a broader effort to develop robotics and automation solutions for pharmaceutical manufacturing, biotechnology, and life sciences environments. PUR-E operates as part of TechForce’s Robotics-as-a-Service Provider (RaaSP) platform, which offers flexible, scalable automation solutions on a subscription basis.
The expansion into sterile manufacturing is critical because it addresses growing labor challenges and productivity demands in highly regulated industries. Nightfood Holdings, doing business as TechForce Robotics, focuses on AI-enhanced robotics and automation across multiple sectors. The company’s vertical integration combines proprietary robotics technology, AI software, real-world operating environments, strategic manufacturing partnerships, and scalable deployment infrastructure.
The collaboration with Oncotelic Therapeutics aims to develop and commercialize intelligent automation solutions for pharmaceutical environments. By integrating advanced robotics, machine vision, and data-driven operational insights, the companies hope to improve workflow consistency and operational efficiency in facilities that require strict contamination control.
For more details, the full press release is available at https://ibn.fm/mXU1p. Additional updates on Nightfood Holdings can be found in the company’s newsroom at http://ibn.fm/NGTF.
The deployment of PUR-E represents a tangible step toward automating clean room processes, which could reduce human error and enhance safety in pharmaceutical manufacturing. As regulatory standards tighten, such automation may become increasingly important for ensuring compliance and maintaining product quality.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Nightfood Holdings Deploys Autonomous Robot in Sterile Pharmaceutical Facility.